Concepedia

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

Sejeong Park, So Young Park, Yu Jin Kim, Soo Min Hong, Suk Chon, Seungjoon Oh, Jeong‐Taek Woo, Sung-Woon Kim, Young Seol Kim, Sang Youl Rhee

Diabetes & Metabolism Journal · 2016 · 12 citations · 17 references

DOIFull text

Open access

Abstract

Rebamipide treatment for 12 weeks improved atypical GI symptoms in patients with T2DM.

References

17

Prevalence of Gastrointestinal Symptoms Associated With Diabetes Mellitus

Peter Bytzer, Nicholas J. Talley, Melanie Leemon et al. · Archives of Internal Medicine · 2001 · 618 citations

Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes

Wayne A. Ray, Katherine T. Murray, Sarah Meredith et al. · New England Journal of Medicine · 2004 · 493 citations · Full text

A Patient Questionnaire to Identify Bowel Disease

Nicholas J. Talley · Annals of Internal Medicine · 1989 · 455 citations

, , +12

Obesity is Associated with Increased Risk of Gastrointestinal Symptoms: A Population-Based Study

Sílvia Delgado-Aros, G. Richard Locke, Michael Camilleri et al. · The American Journal of Gastroenterology · 2004 · 323 citations

The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders

Linda Ganzini · Archives of Internal Medicine · 1993 · 262 citations